Search Within

Jaclyn Frances Hechtman

Formats
  1. Meeting Abstract (104)
  2. Journal Article (99)
  3. Review (4)
  4. Guidelines (2)
  5. Book Section (1)
  6. Correspondence (1)
  7. Research Letter (1)
Groups
  1. Department of Pathology and Laboratory Medicine (179)
  2. Department of Medicine (158)
  3. Solid Tumor Oncology Division (157)
  4. GSK Faculty (147)
  5. Human Oncology and Pathogenesis Program (133)
  6. Gastrointestinal Oncology Service (101)

More Groups

People
  1. Jinru Shia (85)
  2. Marc Ladanyi (69)
  3. Efsevia Vakiani (67)
  4. Michael Berger (66)
  5. David Klimstra (55)
  6. Ahmet Zehir (54)

More People

Years
  1. 2025 (2)
  2. 2024 (2)
  3. 2023 (3)
  4. 2022 (6)
  5. 2021 (18)
  6. 2020 (23)

More Years

Publications
  1. Modern Pathology (37)
  2. Journal of Clinical Oncology (32)
  3. Laboratory Investigation (24)
  4. Clinical Cancer Research (15)
  5. Annals of Oncology (11)
  6. Journal of Molecular Diagnostics (11)

More Publications

Publishers
  1. American Society of Clinical Oncology (41)
  2. Nature Research (37)
  3. American Association for Cancer Research (33)
  4. Nature Publishing Group (31)
  5. Oxford University Press (15)
  6. Elsevier Science, Inc. (13)

More Publishers

Results (212)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TRK XDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
    Journal Article

    Cocco, E.; Lee, J. E.; Kannan, S.; Schram, A. M.; Won, H. H.; Shifman, S.; Kulick, A.; Baldino, L.; Toska, E.; Arruabarrena-Aristorena, A.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Kinase fusions drive endocrine resistance in estrogen receptor-positive breast cancer
    Meeting Abstract

    Liu, B.; Ross, D. S.; Schram, A. M.; Razavi, P.; Lagana, S. M.; Zhang, Y.; Scaltriti, M.; Bromberg, J. F.; Ladanyi, M.; Hyman, D. M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
    Meeting Abstract

    Cocco, E.; Lee, J. E.; Kannan, S.; Schram, A. M.; Won, H. H.; Shifman, S.; Kulick, A.; Baldino, L.; Toska, E.; Arena, S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Rapid assessment of microsatellite instability across a spectrum of tumor types using the IDYLLA system
    Meeting Abstract

    Momeni-Boroujeni, A.; Arcila, M.; Ferguson, D.; Patel, U.; Chan, R.; Barbee, J.; Zehir, A.; Hechtman, J.; Ladanyi, M.; Nafa, K.
    Journal of Molecular Diagnostics (2020)

    Fulltext@MSK | Save
  • Tumor microbiome in colorectal carcinoma: Bacterial enrichment is associated with oncogenic variants within specific signaling pathways
    Meeting Abstract

    Beech, C.; Vanderbilt, C.; Keshinro, A.; Chen, C.; Kim, J.; Hechtman, J.; Zehir, A.; Bowman, A.; Arcila, M.; Ladanyi, M.; more...
    Journal of Molecular Diagnostics (2020)

    Fulltext@MSK | Save
  • ctDNA applications and integration in colorectal cancer: An NCI Colon and Rectal–Anal Task Forces whitepaper
    Guidelines

    Dasari, A.; Morris, V. K.; Allegra, C. J.; Atreya, C.; Benson, A. B. 3rd; Boland, P.; Chung, K.; Copur, M. S.; Corcoran, R. B.; Deming, D. A.; more...
    Nature Reviews Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Molecular epidemiology of IDH2 hotspot mutations in cancer and immunohistochemical detection of R172K, R172G, and R172M variants
    Journal Article

    Dogan, S.; Frosina, D.; Geronimo, J. A.; Hernandez, E.; Mohanty, A.; Bale, T.; Hechtman, J. F.; Arcila, M. E.; Hameed, M. R.; Jungbluth, A. A.
    Human Pathology (2020)

    Fulltext@MSK | Save
  • Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Millang, B. M.; Sabwa, S.; Chou, J. F.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Prevalence and clinical characterization of MMR-D/MSI extra-colonic cancers among germline PMS2 mutation carriers
    Meeting Abstract

    Latham, A.; Salo-Mullen, E. E.; Catchings, A.; Ranganathan, M.; Fiala, E.; Kemel, Y.; Konner, J. A.; Soslow, R. A.; Momeni-Boroujeni, A.; Shia, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Lineage reversion drives WNT independence in intestinal cancer
    Journal Article

    Han, T.; Goswami, S.; Hu, Y.; Tang, F.; Zafra, M. P.; Murphy, C.; Cao, Z.; Poirier, J. T.; Khurana, E.; Elemento, O.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save